Literature DB >> 10353036

MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation.

O Tynninen1, H J Aronen, M Ruhala, A Paetau, K Von Boguslawski, O Salonen, J Jääskeläinen, T Paavonen.   

Abstract

RATIONALE AND
OBJECTIVES: Angiogenesis and proliferation activity are important indicators of tumor behavior in human gliomas. The authors studied how tumor enhancement in MR imaging and intratumoral vascular density were correlated with cell proliferation in cerebral gliomas.
METHODS: The authors studied retrospectively 62 cerebral gliomas. Patients were examined before surgery with contrast-enhanced MR imaging. Microvessel density and the cell proliferation rate of tumor specimens were measured immunohistochemically using factor VIII and MIB-1 antibodies. Contrast enhancement of the tumors was evaluated by two radiologists.
RESULTS: Contrast enhancement was observed in 45 tumors and was correlated with histologic cell proliferation (P = 0.0007) and microvessel density (P = 0.01). There was also a correlation between tumor vascular density and the cell proliferation rate (r = 0.51, P < 0.0001). Histologic tumor grade was associated with vascular density (P = 0.001).
CONCLUSIONS: Lesion enhancement on preoperative contrast-enhanced MR imaging correlates with vascularity and proliferation activity of gliomas. The additional correlation between tumor vascularity and proliferation suggests that intratumoral microvessel density could be useful in estimating tumor proliferation.

Entities:  

Mesh:

Year:  1999        PMID: 10353036     DOI: 10.1097/00004424-199906000-00007

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  27 in total

Review 1.  Descriptive analysis and quantification of angiogenesis in human brain tumors.

Authors:  R D Folkerth
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

2.  Protoporphyrin IX fluorescence contrast in invasive glioblastomas is linearly correlated with Gd enhanced magnetic resonance image contrast but has higher diagnostic accuracy.

Authors:  Kimberley S Samkoe; Summer L Gibbs-Strauss; Harold H Yang; S Khan Hekmatyar; P Jack Hoopes; Julia A O'Hara; Risto A Kauppinen; Brian W Pogue
Journal:  J Biomed Opt       Date:  2011-09       Impact factor: 3.170

3.  Low-field MR imaging of meningiomas including dynamic contrast enhancement study: evaluation of surgical and histopathologic characteristics.

Authors:  S K Yrjänä; H Tuominen; A Karttunen; N Lähdesluoma; E Heikkinen; J Koivukangas
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

Review 4.  The optimal use of contrast agents at high field MRI.

Authors:  Siegfried Trattnig; Kathia Pinker; Ahmed Ba-Ssalamah; Iris-Melanie Nöbauer-Huhmann
Journal:  Eur Radiol       Date:  2006-03-01       Impact factor: 5.315

5.  High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings.

Authors:  K Pinker; I M Noebauer-Huhmann; I Stavrou; R Hoeftberger; P Szomolanyi; G Karanikas; M Weber; A Stadlbauer; E Knosp; K Friedrich; S Trattnig
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

6.  High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors.

Authors:  K Pinker; I M Noebauer-Huhmann; I Stavrou; R Hoeftberger; P Szomolanyi; M Weber; A Stadlbauer; G Grabner; E Knosp; S Trattnig
Journal:  Neuroradiology       Date:  2007-09-18       Impact factor: 2.804

7.  Multifarious proteomic signatures and regional heterogeneity in glioblastomas.

Authors:  Chul-Kee Park; Ji Hye Jung; Sung-Hye Park; Hee-Won Jung; Byung-Kyu Cho
Journal:  J Neurooncol       Date:  2009-02-15       Impact factor: 4.130

8.  Contributions of biological tumor parameters to the incorporation rate of L: -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas.

Authors:  Takeko Nojiri; Tadashi Nariai; Masaru Aoyagi; Michio Senda; Kenji Ishii; Kiichi Ishiwata; Kikuo Ohno
Journal:  J Neurooncol       Date:  2008-12-20       Impact factor: 4.130

9.  The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival.

Authors:  Y S Choi; D W Kim; S-K Lee; J H Chang; S-G Kang; E H Kim; S H Kim; T H Rim; S S Ahn
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-03       Impact factor: 3.825

Review 10.  Intra-tumoural microvessel density in human solid tumours.

Authors:  J Hasan; R Byers; G C Jayson
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.